Sharfstein: devices regulator going through "transitional phase"
This article was originally published in Clinica
The regulation of devices in the US is going through a transitional phase which should result in an improved FDA that can adapt to changing technology while setting clear standards, FDA Commissioner Joshua Sharfstein told medtech executives.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.